skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Bipolar disorders: treatment options and patient satisfaction

(2929) Views  (512) Full article downloads

Authors: Charles Bowden, Vivek Singh

Published Date February 2006 Volume 2006:2(2) Pages 149 - 153
DOI: http://dx.doi.org/10.2147/NDT.S

Charles Bowden, Vivek Singh

Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

Abstract: Functional recovery, the goal of treatment, has long been overlooked in the assessment of effectiveness of pharmacological treatments. However, with the recent shift in paradigm, from syndromal–symptomatic recovery to functional recovery, there appears to be a new interest in the definition and evaluation of functional recovery. Since functional recovery lags symptomatic recovery, sometimes by months or years, the attainment of functional recovery will be determined by both efficacy and long-term compliance. Quetiapine, due to its efficacy in both mania and depression, and effect on cognition may lead to improved functioning in patients with bipolar disorder.

Keywords: bipolar disorders, syndromal recovery, functional recovery, efficacy, effectiveness








Readers of this article also read:

The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder
Editorial: Migraine – a suitable case for treatment? || FREE PAPER ||
Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Bipolar disorder and neurophysiologic mechanisms
A randomized controlled trial of quetiapine for psychosis in Parkinson’s disease
ABO and rhesus blood group distribution in Kurds
Primary care for diabetes mellitus: perspective from older patients
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
Update on the role of antipsychotics in the treatment of Tourette syndrome
Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia